The 1p36 Tumor Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis  by Li, Shuijie et al.
Article
The 1p36 Tumor Suppressor KIF 1Bb Is Required for
Calcineurin Activation, Controlling Mitochondrial
Fission and ApoptosisGraphical AbstractHighlightsd The 1p36 tumor suppressor KIF1Bb is a general regulator of
calcineurin activity
d Calcineurin activation by KIF1Bb causes DRP1-mediated
mitochondrial fission
d KIF1Bb loss causes mitochondrial elongation and failure of
developmental apoptosis
d Escape from neuronal apoptosis during NGF competition
leads to tumor developmentLi et al., 2016, Developmental Cell 36, 164–178
January 25, 2016 ª2016 Elsevier Inc.
http://dx.doi.org/10.1016/j.devcel.2015.12.029Authors
Shuijie Li, Stuart M. Fell,
Olga Surova, ..., Per Uhle´n, Per Kogner,
Susanne Schlisio
Correspondence
susanne.schlisio@licr.ki.se
In Brief
KIF1Bb is a regulator of apoptosis and a
candidate tumor suppressor, located in a
chromosomal region frequently deleted in
neuroblastoma. Li et al. now delineate the
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KIF1Bb is a candidate 1p36 tumor suppressor that
regulates apoptosis in the developing sympathetic
nervous system. We found that KIF1Bb activates
the Ca2+-dependent phosphatase calcineurin (CN)
by stabilizing the CN-calmodulin complex, relieving
enzymatic autoinhibition and enabling CN substrate
recognition. CN is the key mediator of cellular re-
sponses to Ca2+ signals and its deregulation is impli-
cated in cancer, cardiac, neurodegenerative, and
immune disease. We show that KIF1Bb affects mito-
chondrial dynamics through CN-dependent dephos-
phorylation of Dynamin-related protein 1 (DRP1),
causing mitochondrial fission and apoptosis.
Furthermore, KIF1Bb actuates recognition of all
knownCN substrates, implying a general mechanism
for KIF1Bb in Ca2+ signaling and how Ca2+-depen-
dent signaling is executed by CN. Pathogenic
KIF1Bbmutations previously identified in neuroblas-
tomas and pheochromocytomas all fail to activate
CN or stimulate DRP1 dephosphorylation. Impor-
tantly, KIF1Bb and DRP1 are silenced in 1p36 hemi-
zygous-deleted neuroblastomas, indicating that
deregulation of calcineurin and mitochondrial dy-
namics contributes to high-risk and poor-prognosis
neuroblastoma.
INTRODUCTION
Calcineurin (CN) is the key mediator of cellular responses to
intracellular Ca2+ signals, and dysregulation of CN activity is
implicated in cancer, diabetes, and heart, immune, and neurode-164 Developmental Cell 36, 164–178, January 25, 2016 ª2016 Elsevigenerative diseases (Li et al., 2011). CN is a Ca2+-activated and
calmodulin-dependent phosphatase that exists as a hetero-
dimer made up of a catalytic subunit (CNA) in complex with a
regulatory subunit (CNB). CN is enzymatically inhibited by the
CNA autoinhibitory domain under low Ca2+ concentration.
Once the intracellular level of Ca2+ rises, CNA becomes partially
active through Ca2+-dependent binding of calmodulin, which
displaces CNA’s autoinhibitory domain from its active site (Li
et al., 2011). However, a fundamental understanding of full CN
enzymatic activation and what determines substrate recognition
remain elusive. Here, we provide evidence of how tumor sup-
pression by the kinesin KIF1Bb is mediated through enzymatic
activation of CN. Specifically, KIF1Bb activates CN by stabilizing
the CN-calmodulin complex, relieving enzymatic autoinhibition
and enabling substrate recognition. One of the CN substrates
characterized here is the mitochondrial fission protein DRP1.
Mitochondria are highly dynamic and engage in constant fission
and fusion (Lin et al., 2013). Mitochondrial fission is governed by
mitochondrial DRP1 (Lin et al., 2013) and requires translocation
of DRP1 to the mitochondria, controlled by DRP1 phosphoryla-
tion on serine-637 (Knott et al., 2008). When phosphorylated at
Ser637 by protein kinase A (PKA), DRP1 remains inactive in the
cytoplasm (Cribbs and Strack, 2007; Gomes et al., 2011).
Dephosphorylation on Ser637 by CN reverses this inhibition
and DRP1 translocates to the mitochondria to mediate fission
(Cereghetti et al., 2008). Here we report how DRP1-dependent
mitochondrial dynamics are controlled by KIF1Bb. Independent
from its motor function, KIF1Bb has recently been characterized
as a candidate 1p36 tumor suppressor that regulates apoptosis
in the developing sympathetic nervous system (Munirajan et al.,
2008; Schlisio et al., 2008). KIF1Bb is located on human chromo-
some 1p36.2, a region of the genome that is frequently deleted in
neuroblastoma and other forms of neural crest-derived tumors.
We found that KIF1Bb regulates apoptosis by controlling mito-
chondrial fission through CN-dependent regulation of DRP1. In
addition to mediating DRP1 dephosphorylation, we found thater Inc.
Figure 1. KIF1Bb Regulates Mitochondrial Dynamics by Controlling DRP1 Mitochondrial Translocation
(A) Fluorescence images of NB1 cells 36 hr after transfection with plasmid pDsRed-Mito encoding fluorescent mitochondria targeting protein (red) together with
either pcDNA3 plasmids encoding GFP-KIF1Bb-WT (green) or GFP-KIF1Bb mutants. Right: Graphical representation showing quantification of mitochondrial
circularity 36 hr after transfection (mean ± SE, n = 40–60 cells/condition; three independent experiments. ***p < 0.001, ****p < 0.0001).
(B) Fluorescence images of SK-N-SH cells (KIF1Bb+/+) infected with lentivirus encoding shRNA targeting KIF1Bb (shKIF1Bb) or non-targeting control (shSCR) and
subsequently transfected with plasmid pDsRed-Mito (red) to visualize mitochondria. Nuclei are counterstained using DAPI (blue). Right: Graphical representation
(legend continued on next page)
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KIF1Bb actuates recognition of all known CN substrates,
providing a general mechanism for KIF1Bb in Ca2+ signaling
and how CN executes Ca-dependent signaling.
RESULTS
KIF1Bb Regulates Mitochondrial Dynamics by
Controlling DRP1 Mitochondrial Translocation
We studied the effects of KIF1Bb on mitochondrial morphology
using the neuroblastoma cell line NB1, which has a 500-kb ho-
mozygous deletion at 1p36.2 spanning the KIF1B locus (Krona
et al., 2003; Nagai et al., 2000; Yang et al., 2001). NB1 cells
were cotransfected with plasmids encoding KIF1Bb and a mito-
chondria-targeted fluorescent protein (pDsRed2-Mito). We
observed filamentous mitochondria in control cells (Figure 1A).
However, ectopic expression of GFP-KIF1Bb caused significant
mitochondrial fragmentation (assessed by mitochondrial circu-
larity) prior to onset of apoptosis. The apoptosis-inducing region
of KIF1Bb was previously mapped to amino acid residues 600–
1400 and does not include the motor domain (Chen et al.,
2014). Similar to GFP-KIF1Bb wild-type, GFP-KIF1Bb600-1400
induced significant mitochondrial fragmentation, in contrast to
the non-apoptotic mutant KIF1Bb600-1200, which caused no
significant mitochondrial changes (Figure 1A). To understand
whether the observed mitochondrial fragmentation is a conse-
quence of apoptosis or whether it is directly mediated by
KIF1Bb, we investigated mitochondrial morphology upon
KIF1Bb knockdown in 1p36-positive neuroblastoma cells
(KIF1Bb+/+). SK-N-SH or SK-N-F1 cells (KIF1Bb+/+) transduced
with shRNA’s targeting KIF1Bb displayed significantly elongated
and hyperfused mitochondria compared with control cells (Fig-
ures 1B, S1A, and S1B). Mitochondrial fission depends on trans-
location of dynamin-related protein 1 (DRP1) from the cytosol to
the mitochondria. We observed endogenous DRP1 in the cyto-
plasm of NB1 cells, but ectopic expression of GFP-KIF1Bb or
GFP-KIF1Bb600-1400 induced colocalization of DRP1 with
mitochondria (Figure 1C). However, the non-apoptotic mutant
GFP-KIF1Bb600-1200 had no effect on DRP1 distribution (Fig-
ure 1C). Immunoblot of mitochondrial and cytosolic cell fractions
confirmed these observations (Figure 1D). Conversely, knock-
down of KIF1Bb in SK-N-SH or SK-N-F1 cells (KIF1Bb+/+) moved
DRP1 from the mitochondria into the cytoplasm (Figure 1E and
S1C). Next, we investigated DRP1 phosphorylation, since phos-
phorylation on Ser637 has been demonstrated to control DRP1
mitochondrial localization (Knott et al., 2008). Ectopically ex-showing quantification of mitochondrial circularity (mean ± SE, n = 40–60 cells/con
of SK-N-SH cells verifying KIF1Bb knockdown efficiency.
(C) Immunofluorescence images of NB1 cells 36 hr after transfection with plasmi
encoding either FLAG-KIF1Bb-WT or GFP-KIF1Bbmutants (CY5 647 purple). NB1
(blue). Right: Graphical representation showing quantitative analysis of DRP1:: m
transfection (mean ± SE, n = 40–60 cells/condition; three independent experime
(D) Anti-DRP1 immunoblot of mitochondrial and cytoplasmic fractions isolated
KIF1Bb600-1400 (proapoptotic domain) or apoptotic-dead mutant FLAG-KIF1Bb
(E) Anti-DRP1 immunoblot of mitochondrial and cytoplasmic fractions from S
(shKIF1Bb) or non-targeting control (shSCR).
(F) Anti-P-DRP1(Ser637) immunoblot of whole-cell lysate (WCL) from NB1 cells
KIF1Bb600-1200.
(G) Anti-P-DRP1(Ser637) immunoblot (WCL) of SK-N-SH cells that were transdu
(H) Anti-P-DRP1(Ser637) immunoblot of dissected superior cervical ganglion from
166 Developmental Cell 36, 164–178, January 25, 2016 ª2016 Elsevipressed FLAG-KIF1Bb600-1400 reduced DRP1-S673 phos-
phorylation in NB1 cells, while non-apoptotic KIF1Bb600-1200
had no effect (Figure 1F). Conversely, knockdown of KIF1Bb
(KIF1Bb+/+) increased phosphoserine 637 on DRP1 in SK-N-SH
(Figure 1G) and SK-N-F1 cells (Figure S1D). To confirm these ob-
servations in vivo, we analyzed superior cervical ganglia (SCG)
from mice in which KIF1Bb is specifically inactivated in sympa-
thetic neurons by Cre-recombinase expressed under the control
of the DBH promoter (KIF1Bbfl/flDBHCre) (Figures S2A–S2D).
Immunoblots of superior cervical ganglia (SCG) from these
KIF1Bbfl/flDBHCre mice showed a significant increase in phos-
pho-DRP1 at Ser637, compared with wild-type littermate con-
trols, indicating that KIF1Bb controls mitochondrial dynamics
through regulation of P-DRP1 on Ser637 in vivo (Figure 1H).
The steady state level of other mitochondrial fusion mediators
such as MFN1/2 and OPA1 and the mediator of mitochondrial
biogenesis such as TFAM remained unchanged upon KIF1Bb
gain or loss in NB1 or SK-N-SH cells, respectively (Figures S1E
and S1F).
Loss of DRP1 Blocks KIF1Bb-Induced Apoptosis and
Promotes Neuronal Survival under Neurotrophin
Deprivation
Since KIF1Bb regulates apoptosis in the developing sympathetic
nervous system, we asked whether DRP1 is necessary for
KIF1Bb to induce apoptosis. Similar to previous studies (Chen
et al., 2014; Schlisio et al., 2008), KIF1Bb600-1400 induced
apoptotic changes in the nuclei of 59% of transfected cells. In
contrast, knockdown of DRP1 by shRNA prevented
KIF1Bb600-1400-induced apoptosis compared with control
cells (shSCR) (Figure 2A). Knockdown of DRP1 stimulated mito-
chondrial fusion and the formation of giant large mitochondrial
aggregates (Figure 2B and quantified by assessment of mito-
chondrial interconnectivity in Figure 2D). Furthermore, KIF1Bb
failed to promote mitochondrial fragmentation in shDRP1 cells,
implying that DRP1-mediated mitochondrial fission is required
for KIF1Bb-induced apoptosis (Figures 2B and 2C).
KIF1Bb has been proposed to act as a tumor suppressor by
regulating NGF-dependent developmental apoptosis in the sym-
pathetic nervous system (Chen et al., 2014; Schlisio et al., 2008).
We therefore investigated DRP1’s role in mitochondrial dy-
namics and apoptosis following NGF deprivation in primary
cultures ofmouse sympathetic neurons. NGFwithdrawal caused
a rapid decrease in DRP1 phosphorylation on Ser637 within 8 hr,
a time when cells have not yet committed to apoptosisdition; three independent experiments. ***p < 0.001). Anti-KIF1Bb immunoblot
d pDsRed-Mito visualizing mitochondria (red) together with pcDNA3 plasmids
cells were stained for endogenous DRP1 (green) and counterstained with DAPI
itochondria colocalization (P.C. = Pearson’s coefficient) in NB1 cells 36 hr after
nts. ***p < 0.001, ****p < 0.0001).
from NB1 cells following transduction of lentivirus encoding either FLAG-
600-1200.
K-N-SH cells transduced with lentivirus encoding shRNA targeting KIF1Bb
transduced with lentivirus encoding either FLAG-KIF1Bb600-1400 or FLAG-
ced with lentivirus encoding shRNA targeting KIF1Bb or scramble control.
4-week-old mice of the indicated genotype.
er Inc.
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Figure 2. Loss of DRP1 Blocks KIF1Bb-In-
duced Apoptosis and Promotes Neuronal
Survival under Neurotrophin Deprivation
(A) Percentage of NB1 cells exhibiting apoptotic
changes, visualized with GFP-histone, 48 hr after
cotransfection with the indicated pLKOshRNA-
plasmids together with plasmid encoding RFP-
KIF1Bb600-1400. Only double-positive cells for
GFP and RFP were scored (mean ± SD; n = 3; *p <
0.05). DRP1 knockdown efficiency is shown by
anti-DRP1 immunoblot.
(B) Immunofluorescence images of NB1 cells 36 hr
after transfection with pDsRed-Mito plasmid
encoding fluorescent mitochondria targeting pro-
tein (red) together with plasmid encoding GFP-
KIF1Bb-WT (green) in combination with
pLKOshRNA plasmid targeting DRP1.
(C and D) Mitochondrial circularity was examined
to assess mitochondrial fragmentation 36 hr
after transfection (C) and mitochondrial inter-
connectivity was quantified to assess mito-
chondrial hyperfusion (D). Only double-positive
cells for GFP and RFP were scored (mean ± SE,
n = 40–60 cells/condition; three independent ex-
periments. **p < 0.01, ***p < 0.001).
(E) Immunoblot of primary mouse sympathetic
neurons subjected to NGF withdrawal at indicated
times.
(F) Immunoblot of differentiated PC12 cells before
(+) and after () NGF withdrawal as indicated. Prior
to NGF withdrawal, cells were transduced with
lentivirus encoding short hairpins targeting KIF1Bb
(shKIF1Bb) or non-targeting control virus (shSCR).
(G) Primary rat sympathetic neurons were electro-
porated with the indicated pLKO-shDRP1
plasmids, subjected to NGF withdrawal, and GFP-
positive cells were analyzed for apoptotic DAPI-
stained nuclei (mean ± SD; n = 3; **p < 0.01, ***p <
0.001). DRP1 knockdown efficiency is shown by
anti-DRP1 immunoblot.(Figure 2E). To understand if the rapid decline in phospho-DRP1
depends upon KIF1Bb, we transduced NGF-differentiated PC12
cells with shRNA targeting KIF1Bb. In control cells (shSCR),
DRP1 phosphorylation on Ser637 decreased within 2 hr of
NGF deprivation. In contrast, KIF1Bb knockdown blocked
dephosphorylation of DRP1 after NGF withdrawal (Figure 2F).
Furthermore, shRNA targeting DRP1 blocked neuronal
apoptosis induced byNGFwithdrawal in primary rat sympathetic
neurons, implying that mitochondrial DRP1 is required for devel-
opmental apoptosis in sympathetic neurons that compete for
NGF during development (Figure 2G).
Calmodulin 2 and Calcineurin A Are Required for
KIF1Bb-Mediated DRP1 Mitochondrial Translocation
and Apoptosis
To understand mechanistically how KIF1Bb regulates DRP1
dephosphorylation, we performed large-scale KIF1Bb immuno-
precipation to search for proteins that interact with the KIF1Bb
proapoptotic domain (amino acids [aa] 600–1400). NB1 cells
were transiently transduced with Stag-Flag-KIF1Bb600-1400
lentivirus and bound proteins were analyzed by mass spectrom-Developmetry (Figure 3A). Among the proteins identified was calmodulin 2
(CALM2) (Figure 3A). The association between KIF1Bb and
CALM2 was confirmed in 1p36-positive neuroblastoma cells
(SH-SY5Y) by co-immunoprecipitation of endogenous KIF1Bb
with endogenous CALM2 (Figure 3B). CALM2 is a Ca2+ sensor
and adaptor protein that facilitates the activity of a large number
of Ca2+-dependent kinases and phosphatases including CN, a
serine/threonine-specific protein phosphatase (Rumi-Masante
et al., 2012; Yang and Klee, 2000). Importantly, CN dephosphor-
ylates DRP1 on Ser637, stimulating DRP1mitochondrial translo-
cation (Cereghetti et al., 2008). Therefore, we asked if
KIF1Bb binding toCALM2 is necessary for CN to dephosporylate
DRP1.
We first tested if the KIF1Bb600-1400 proapoptotic domain
also co-precipitated with the CN catalytic subunit CNA and
DRP1. We observed interaction between ectopically expressed
FLAG-KIF1Bb(600–1400) and endogenous CALM2, CNA, and
DRP1 (Figure 3C). This interaction was specific, since CALM2,
CNA, and DRP1 did not co-precipitate with non-apoptotic
KIF1Bb(600–1200) (Figure 3C). Next, we asked if KIF1Bb directly
interacts with CNA, independent of CALM2. In vitro translatedental Cell 36, 164–178, January 25, 2016 ª2016 Elsevier Inc. 167
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Figure 3. Calmodulin 2 and Calcineurin A
Are Required for KIF1Bb-Mediated DRP1
Mitochondrial Translocation and Apoptosis
(A) Large-scale KIF1Bb immunoprecipitation in
NB1 cells that were transduced with lentivirus en-
coding Stag-Flag-KIF1Bb600-1400. Silver-stained
gel indicates (arrow) identified co-immunoprecipi-
tated proteins and table listing peptides identified
by mass spectrometry.
(B) Immunoblot showing co-immunoprecipitation
of endogenous calmodulin II (CALM2) and endog-
enous KIF1Bb in SH-SY5Y cells that were immu-
noprecipitated with CALM2 antibody.
(C) Immunoblot of NB1 cells transfected with
plasmids encoding Flag-KIF1Bb600-1400 or
KIF1Bb600-1200 and immunoprecipitated with
anti-Flag antibody.
(D) Schematic of KIF1Bb deletionmutants and their
ability to induce cell death, CALM2 and CNA
binding, and DRP1 substrate recognition. Red as-
terisks indicate the locations of mutations associ-
ated with disease.
(E) Immunoblot of whole-cell lysates from NB1
transduced with lentiviral pLKOshRNA targeting
CNA (shCNA) or CALM2 (shCALM2) or non-tar-
geting control (shSCR). Stable clones were
transiently transduced for 48 hr with lentivirus en-
coding either empty control or FLAG-KIF1Bb600-
1400.
(F) Immunoblot blot of mitochondrial and cyto-
plasmic fractions from NB1 cells transduced with
lentivirus as in (E).
(G) NB1 cells transfected with plasmid encoding
GFP-KIF1Bb in combination with pLKO-plasmids
encoding shSCR, shCNA, or sh-CALM2. Shown is
the % of nuclei exhibiting apoptotic changes 48 hr
after transfection (mean ± SD; n = 3; **p < 0.01,
***p < 0.001). Right: rat-CALM2 and rat-CNA
knockdown efficiency is shown by immunoblot.
(H) Primary rat sympathetic neurons were electro-
porated with the indicated pLKO-shRNA plasmids,
subjected to NGF withdrawal, and GFP-positive
cells were analyzed for apoptotic DAPI-stained
nuclei (mean ± SD; n = 3; **p < 0.01). Right: rat-CNA
and rat-CALM2 knockdown efficiency is shown by
immunoblot.35S-labeled wild-type KIF1Bb, KIF1Bb600-1400, but not
apoptotic mutant KIF1Bb600-1200, co-immunoprecipitated
with in vitro translated CNA (Figure S3A). In contrast, mutant
KIF1Bb600-1200 is still capable of binding CALM2, however it
failed to bind to KIF1Bb600-1400D1100-1300 (Figures 3D and
S3B). Thus, we identified two separate binding sites for
CALM2 and CNA within the apoptotic region of KIF1Bb. The
CALM2 binding site is located from aa 1100–1200 and adjacent
to this site is the CNA-binding region at aa 1300–1400 (Figures
3D, S3A, and S3B). In addition, we performed in vitro KIF1Bb
binding studies with CALM2 and CNA in the presence or
absence of Ca2+ (Figures S3C and S3D). The direct binding of
KIF1Bb to CALM2 or CNA does not require Ca2+. However,
CNA binding to a P-Ser637-DRP1 peptide that contained the
LxVP motif required for CNA recognition (Rodriguez et al.,
2009; Slupe et al., 2013) remains Ca2+ dependent (Figure S3E)
and requires the presence of CALM2. Although KIF1Bb can168 Developmental Cell 36, 164–178, January 25, 2016 ª2016 Elsevidirectly associate with CALM2 and CNA in the absence of
Ca2+, CNA substrate binding to P-DRP1 is Ca2+ dependent,
since Ca2+ is required for the CALM2-CNA interaction as previ-
ously described (Li et al., 2011).
Next we asked whether KIF1Bb-stimulated DRP1 dephos-
phorylation is executed by CALM2 and CNA. Ectopic expression
of KIF1Bb promoted DRP1 dephosphorylation on Ser637 in con-
trol cells (shSCR), whereas knockdown of CALM2 or CNA with
shRNA blocked KIF1Bb-stimulated DRP1 dephosphorylation
(Figure 3E). KIF1Bb also failed to inducemitochondrial transloca-
tion of DRP1, or apoptosis, upon knockdown of CALM2 or CNA
in NB1 cells (Figures 3F and 3G). Furthermore, knockdown of
CNA and CALM2 impairs apoptosis of primary sympathetic neu-
rons following neurotrophin deprivation (Figure 3H) to the same
extent as loss of DRP1 expression (Figure 2G). Thus, CALM2
and its associated phosphatase CN are required for KIF1Bb-me-
diated DRP1 dephosphorylation, subsequent mitochondrialer Inc.
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Figure 4. KIF1Bb Regulates CNA Enzymatic Activity and Substrate Recognition
(A) Endogenous CALM2 immunoprecipitation followed by anti-CNA, DRP1, and CALM2 immunoblot of SK-N-SH cells (1p36+/+) that were transduced with
lentivirus encoding shRNA targeting KIF1Bb or scramble control.
(B) Endogenous CALM2 immunoprecipitation followed by anti-CNA, DRP1, and CALM2 immunoblot of NB1 cells (KIF1Bb/) that were transduced with lentivirus
encoding FLAG-KIF1Bb or empty control virus.
(C) CNA activity measured by using biotinylated phospho-DRP1 peptide as substrate as shown. The peptide was incubated in the presence or absence of in vitro
translated S35KIF1Bb wild-type, S35KIF1Bb600-1400 or mutant S35KIF1Bb600-1200 in combination with in vitro translated S35CALM2 and/or S35CNA and
S35CNB. The peptide was subsequently captured with streptavidin agarose. Shown is the immunoblot of p-DRP1 peptide using an anti-P-DRP1(Ser637)
(legend continued on next page)
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translocation, mitochondrial fission, and induction of apoptosis
in both neuroblastoma cell lines and neurons.
KIF1Bb Regulates CNA Enzymatic Activity by Stabilizing
the CNA-Calmodulin Complex
We next investigated how KIF1Bb regulates CN-dependent
DRP1 dephosphorylation. CN phosphatase requires binding of
the Ca2+-adaptor protein CALM2 to the CN catalytic subunit
CNA (Li et al., 2011). Since we identified CALM2 and CNA as
KIF1Bb binding partners, we tested whether KIF1Bb is required
for CALM2-CNA association and/or if KIF1Bb mediates CNA-
DRP1 substrate recognition. In SK-N-SH control cells (shSCR),
endogenous CALM2 immunoprecipitated together with endoge-
nous CNA and DRP1, however, knockdown of KIF1Bb elimi-
nated these interactions (Figure 4A). Meanwhile, another
CALM2-dependent enzyme, calmodulin-dependent protein
kinase II (CaMKII) co-precipitated together with CALM2 inde-
pendent of KIF1Bb expression, indicating that KIF1Bb specif-
ically regulates the CNA-CALM2 complex. Conversely, ectopic
expression of FLAG-KIF1Bb600-1400 in NB1 cells (KIF1Bb/)
enhanced the interaction between CALM2 and CNA in compar-
ison with control cells, which displayed only a weak association
(Figure 4B). Moreover, KIF1Bb induced co-precipitation of
DRP1, in contrast to non-transduced cells where DRP1 failed
to co-precipitate with the CALM2-CNA complex (Figure 4B).
We infer that KIF1Bb might stabilize the CNA-CALM2 complex
and is potentially required for CNA substrate recognition.
Indeed, immunoprecipitation of endogenous CNA co-precipi-
tated DRP1 in SK-N-SH control cells (KIF1Bb+/+), but failed
upon KIF1Bb knockdown (Figure S4A). Interaction between
CNA and its regulatory subunit, calcineurin B (CNB) was, how-
ever, not affected by the loss of KIF1Bb. We conclude that
KIF1Bb is required for CNA-CALM2 association and enables
DRP1 substrate recognition.
We considered the possibility that KIF1Bb might potentiate
CNA-CALM2 binding by affecting intracellular Ca2+ concentra-
tions, since CNA binds CALM2 with higher affinity in Ca2+-satu-
rated conditions (O’Donnell et al., 2011). Performing real-time
calcium imaging in single cells, we found that KIF1Bb knock-
down or overexpression did not lead to any significant changes
in basal Ca2+ concentration (Figure S4B). Therefore, we studied
the effect of KIF1Bb on CN activity in Ca2+-saturated conditionsantibody. Streptavidin-HRP detected total biotinylated peptide for loading con
S35-autoradiography and endogenous expression of CNB in reticulocyte lysate i
(D) CNA activity measured by colorimetric phosphate release from p-DRP1-pept
0.025 mM CALM2) and in vitro translated/purified KIF1Bb wild-type (WT) or muta
KIF1Bb600-1400(D1100-1300) (mean ± SD; n = 3; ***p < 0.001).
(E) CNA enzymatic activity was performed as in (C) and followed by p-DRP1 peptid
disease-causing variants in combination with in vitro translated S35CALM2 and S3
S35-autoradiography.
(F) CNA enzymatic activity as in (D) using in vitro translated/purified KIF1Bb-WT o
from CNA enzymatic reactions.
(G) Graphical representation of mitochondrial circularity and DRP1 mitochondrial
FLAG-KIF1Bb-WT or FLAG-KIF1Bb variants, followed by labelingwith CY5 647 (pu
with DAPI to visualize nuclei (blue). Immunofluorescence images are shown in Figu
**p < 0.01, ***p < 0.001, ****p < 0.0001) and quantitative analysis of DRP1:: mitoc
(H) P-DRP1 peptide-binding assay with in vitro translated S35CNA, S35CALM2,
control. Binding reactions were performed in Ca2+ saturated conditions. S35CNA
KIF1Bb was detected by anti-Flag immunoblot.
170 Developmental Cell 36, 164–178, January 25, 2016 ª2016 Elseviin vitro using a P-Ser637-DRP1 peptide that contained the LxVP
motif required for CN binding (Rodriguez et al., 2009; Slupe et al.,
2013). CALM2, KIF1Bb, CNA, and CNB proteins were synthe-
sized in vitro using a reticulocyte lysate system. Dephosphoryla-
tion of P-DRP1 peptide by CNA/B and CALM2 occurred only in
the presence of KIF1Bb (Figure 4C), implying that KIF1Bb is
required for CN phosphatase activity. We noted that unpro-
grammed reticulocyte lysate had a high abundance of CNB
(R.L.-CNB in Figure 4C) and thus in vitro translated CNB was
dispensable in these reticulocyte-based CN enzymatic assays
(last lane Figure 4C). In accord with our previous co-immuno-
precipitation assay (Figure 3C), KIF1Bb’s proapoptotic domain
600–1400 mediated DRP1 dephosphorylation, while the non-
apoptotic mutant KIF1Bb600-1200 did not (Figure 4C). In addi-
tion, we performed CNA phosphatase assays with recombinant
purified CN and quantified phosphate release from p-DRP1-
peptide by colorimetry. We found a strong synergistic effect
when purified KIF1Bb was added (Figure 4D). However, CNA
activity can be measured without the addition of KIF1Bb when
used at high concentrations as provided in commercial kits (Fig-
ure S4C), likely because a partially active enzyme at high con-
centration can still de-phosphorylate an observable amount of
substrate. We therefore titered the activity of recombinant CN
enzyme and determined the onset of enzymatic activity (Fig-
ure S4C). Addition of KIF1Bb had a strong synergistic effect on
CN activity (5- to 6-fold increase) when the amount of CN
enzyme was decreased in the standard in vitro assay (1/10 dilu-
tion in Figure 4D). Furthermore, the non-apoptotic KIF1Bb mu-
tants that fail to either bind CNA (600–1200) or to bind CALM2
(600-1400-D11001400) failed to activate CNA. Next, we exam-
ined disease-associated KIF1Bb variants recently identified in
neuroblastoma and pheochromocytoma (Schlisio et al., 2008;
Welander et al., 2014) for their ability to regulate CN-dependent
DRP1 dephosphorylation and mitochondrial translocation (Fig-
ures 4E–4G). All KIF1Bb disease variants failed to mediate
P-DRP1 dephosphorylation in vitro (Figure 4E), failed to activate
CNA (Figure 4F), failed to bind CNA or CALM2 (Figures S4D and
S4E), failed to promote DRP1mitochondrial translocation in NB1
cells, and induced significantly less mitochondrial fragmentation
than wild-type KIF1Bb (Figures 4G and S4F).
We then asked if KIF1Bbmight act as a scaffold through direct
interaction with CALM2 and CNA to enable CNA substratetrol. Expression of in vitro translated proteins of each reaction is shown by
s shown by immunoblot.
ide using recombinant/purified CNA/CALM2 (1/10 dilution = 4 U of CNA/B and
nts as indicated (6-14 = KIF1Bb600-1400, 6-12 = KIF1Bb600-1200, D11-13 =
e immunoblot. Peptide was incubated with in vitro translated S35KIF1Bb-WT or
5CNA/B. Expression of in vitro translated proteins in each reaction is shown by
r disease-associated variants (mean ± SD; n = 3; ***p < 0.001). Right: 5% input
colocalization in NB1 cells transfected with pDsRed-Mito together with either
rple). NB1 cells were stained for endogenous DRP1 (green) and counterstained
re S4F (mean ± SE, n = 40–60 cells/condition; three independent experiments.
hondria colocalization (Pearson’s coefficient).
and Flag-KIF1Bb as indicated. Scramble-peptide (SCR) served as negative
and S35CALM2 translated proteins were detected by autoradiography, Flag-
er Inc.
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Figure 5. A General Mechanism for KIF1Bb in Regulating CNA Signaling
(A) Endogenous CNA-immunoprecipitation followed by immunoblot of known CNA substrates in SK-N-SH cells (1p36+/+) that were transduced with lentivirus
encoding shRNA targeting KIF1Bb or scramble control. CNB is the regulatory subunit of CNA and served as control.
(B) Anti-P-DRP1(Ser637), p-SMAD1/5(Ser463/465), p-NFAT2(Ser213/217/221) and p-GSK3(Ser9) immunoblot of whole-cell lysates (WCL) of SK-N-SH cells that
were transduced with lentivirus encoding shRNA targeting KIF1Bb (sh-KIF1Bb #3 and #5) or non-targeting control (shSCR) as indicated. GAPDH served as
loading control.
(C) CNA enzymatic activity measured by colorimetric phosphate release from P-RII-peptide using recombinant/purified CNA/CALM2 (1/10 dilution = 4 U of
CNA/B and 0.025 mMCALM2) and in vitro translated/purified KIF1Bb as indicated (mean ± SD; n = 3; ****p < 0.0001). Right: 5% input verifying proteins loaded for
each reaction.
(legend continued on next page)
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recognition. To test this, we examined CNA substrate binding to
the P-DRP1 peptide (Figure 4H). Flag-KIF1Bb, S35CNA, and
S35CALM2 were synthesized in reticulocyte lysate for the pep-
tide-binding assay under Ca2+ saturated conditions. We did
not synthesize CNB, since reticulocyte lysate contained abun-
dant CNB (Figure 4C). We observed little S35CNA binding to
the P-DRP1 peptide, even in the presence of CALM2 (Figure 4H).
In contrast, addition of wild-type Flag-KIF1Bb or Flag-
KIF1Bb600-1400 drastically enhanced S35CNA binding to
DRP1 peptide and enabled co-precipitation of CALM2 and
Flag-KIF1Bb, indicating that KIF1Bb enhances substrate recog-
nition and stabilizes the CNA-CALM2 complex. Importantly, the
non-apoptoticmutant KIF1Bb600-1200, which does notmediate
DRP1 dephosphorylation (Figure 1F) and fails to bind CNA (Fig-
ure S3A), failed to enhance CNA-DRP1 peptide binding or co-
precipitation of CALM2 (Figure 4H). Furthermore, we tested the
ability of additional CNA- and CALM2-binding mutants to
mediate p-DRP1 substrate recognition. KIF1Bb mutants that
failed to bind CALM2 but bind to CNA (1200–1600 and 600-
1400del1100-1300) showed very weak binding to the p-DRP1
peptide (Figure S4G) and failed to activate CNA (Figure 4D), indi-
cating that direct interaction between KIF1Bb and CALM2 is
required to mediate proper CNA substrate recognition. In addi-
tion, KIF1Bb mutants that do not bind CNA but bind CALM2
(1200–1600 and 600-1400D1100-1300) did not mediate sub-
strate recognition (Figures S4G and 3D). Thus, full CN enzymatic
activity is achieved by the mutual binding of KIF1Bb to both
CALM2 and CNA. We conclude that KIF1Bb acts as a direct
scaffold for CALM2 and CNA, facilitating the formation and
stabilization of the CALM2-CNA complex, relieving CNA autoin-
hibition, and thus enabling full substrate recognition.
KIF1Bb Regulates a Wide Range of Calcineurin
Substrates, Providing a General Mechanism of
Calcineurin Activation and Substrate Recognition
The factors that determine CN substrate recognition are poorly
understood. Two substrate binding motifs have been identified:
PxIxIT and LxVP (Li et al., 2011). DRP1 contains the LxVP motif
close to critical phosphoserine 637 (Slupe et al., 2013). Since
we observed that KIF1Bb is required for CN to bind and dephos-
phorylate DRP1, we asked if KIF1Bb might mediate recognition
and dephosphorylation of other known CN substrates. We
focused our attention on characterized substrates: NFAT,
KSR2, GSK3b, Smad1, Dynamin1, and ASK1 (Bodmer et al.,
2011; Cho et al., 2014; Dougherty et al., 2009; Kim et al., 2009;
Li et al., 2011; Liu et al., 2006) (Figures 5A and 5B, and S5A).
These substrates and CALM2 co-immunoprecipitated with
CNA in SK-N-SH (KIF1Bb+/+) cells, however, loss of KIF1Bb pre-(D) Biotinylated NFAT2 peptide containing the LxVP motive was used in a bin
S35KIF1Bb. Binding reaction to the LxVP-mutant peptide served as negative con
S35CALM2, and S35KIF1Bb in vitro translated proteins were detected by autora
reaction.
(E) Peptide-binding assay using biotinylated P-ASK1 and DHX9 peptides that we
Biotinylated scramble-peptide (SCR) served as negative control.
(F) Endogenous CNA-immunoprecipitation followed by immunoblot of DHX9 in S
targeting KIF1Bb or scramble control. Co-immunoprecipitation of CNB served a
(G) Immunofluorescence images of NB1 cells (KIF1Bb/) infected with lentivirus
and subsequently transfected with plasmids encoding RFP-KIF1Bb-WT (red) o
nuclear or cytoplasmic eCFP-DHX9 localization (mean ± SE, n = 80–120 cells/co
172 Developmental Cell 36, 164–178, January 25, 2016 ª2016 Elsevivented these interactions (Figure 5A) as in our previous observa-
tions with DRP1 (Figure 4A). Co-precipitation of the regulatory
subunit CNB was not affected by loss of KIF1Bb. Similarly,
CNA and its substrates ASK1, NFAT2, and KSR2 co-immuno-
precipitated with endogenous CALM2 but not in KIF1Bb knock-
down cells (Figure S5A). Next, we evaluated the phosphorylation
sites on SMAD1/5, GSK3b, and NFAT2 that are targeted by CN.
As shown earlier, knockdown of KIF1Bb in SK-N-SH cells
increased DRP1 phosphorylation on Ser637. Likewise, KIF1Bb
knockdown caused an increase in phospho-SMAD1/5 on
Ser463/465, phospho-NFAT2 on Ser213/217/221 and phos-
pho-GSK3 on Ser9, implying that recognition of other CN sub-
strates, besides DRP1, depends upon KIF1Bb (Figure 5B). In
addition, we performed in vitro CN enzymatic assays on a
P-Ser967-ASK1 peptide (Figure S5B) and P-RII peptide (Fig-
ure 5C). Similar to the P-DRP1 peptide, the targeted P-serines
on ASK1 and RII are adjacent to an LxVP motive (Liu et al.,
2006). As seen with the P-DRP1 peptide (Figure 4C), only enzy-
matic reactions containing CN, CALM2, and KIF1Bb de-phos-
phorylated the P-ASK1 and P-RII peptide, while the absence of
KIF1Bb prevented dephosphorylation of P-ASK1 and P-RII (Fig-
ures 5C, S5B, and S5C).
Next, we examined KIF1Bb-dependent CN substrate recogni-
tion, using P-ASK1 and NFAT2 peptides for assaying S35CNA
binding (Figures 5D and 5E). A scrambled peptide (SCR) and
an NFAT2-LxVP-mutant peptide served as negative controls
(Figure S5D). As observed with the P-DRP1 peptide (Figure 4H),
reticulocyte synthesized CNA bound very weakly to P-ASK1 and
NFAT2 peptides. In contrast, addition of Flag-KIF1Bb enhanced
CNA binding and caused co-precipitation of S35CALM2 and
Flag-KIF1Bb (Figures 5D and 5E), implying a general mechanism
in which KIF1Bb enhances CN substrate recognition. Thus,
KIF1Bb is required for CN activity in general and it affects a
wide range of other known and unknown CN substrates. In this
regard, we revisited our recent findings that demonstrate how
KIF1Bb causes nuclear accumulation of RNA helicase A
(DHX9) and subsequent induction of the proapoptotic XIAP-
associated factor 1 (XAF1) (Chen et al., 2014). In that study, the
mechanism behind KIF1Bb-mediated DHX9 nuclear transloca-
tion remained elusive. Here, we show that DHX9 contains a CN
recognition motif (LxVP) at aa 647–650 (Figure S5D) and investi-
gated KIF1Bb-dependent CN binding to a DHX9 peptide con-
taining the LxVP site. Similar to the DRP1, NFAT2, and ASK1
peptides, DHX9 peptide bound CNA efficiently only in the pres-
ence of KIF1Bb (Figure 5E). In addition, endogenous DHX9 co-
immunoprecipitated with CNA in SK-N-SH (KIF1Bb+/+) cells,
however, loss of KIF1Bb (shKIF1Bb) prevented this interaction
(Figure 5F) as in our previous observations with DRP1ding assay and incubated with in vitro translated S35CNA, S35CALM2, and
trol. Binding reactions were performed in Ca2+ saturated conditions. S35CNA,
diography. Input shows expression of in vitro translated S35proteins of each
re incubated with in vitro translated proteins as indicated and described in (D).
K-N-SH cells (1p36+/+) that were transduced with lentivirus encoding shRNA
s control.
encoding shRNA targeting CNA or non-targeting control (shSCR) as indicated
r eCFP-DHX9 (green). Graphical representation (%) of transfected cells with
ndition; three independent experiments. ***p < 0.001, ****p < 0.0001).
er Inc.
A B
C
D E
Figure 6. Tumorigenic, Gain-of-Function,
PKA Mutant Enhances DRP1 Phosphoryla-
tion on Ser637 and Blocks KIF1Bb-Induced
Apoptosis
(A) % of GFP-positive nuclei exhibiting apoptotic
changes 72 hr after transfection of NB1 cells with
plasmid encoding GFP-histone along with plasmid
encoding RFP-KIF1Bb600-1400 in combination
with plasmid expressing wild-type PKA (WT) or
gain-of-function mutant PKA L206R. Only double-
positive cells for GFP and RFP were scored
(mean ± SD; n = 3; *p < 0.05).
(B) Immunoblot of NB1 cells stable transfected with
plasmids encoding PKA-WT, PKA-L206R or empty
control and subsequently transduced with lenti-
virus encoding Flag-KIF1Bb or empty virus as
indicated.
(C) Immunoblot of S-K-N-SH and SK-N-F1 cells
(1p36+/+) with stable transfection of plasmids en-
coding PKA-WT, PKA-L206R or empty control.
(D and E) Immunoblot of mitochondrial and cyto-
plasmic fractions isolated from SK-N-SH (1p36+/+)
(D) and SK-N-F1 cells (1p36+/+) (E) with stable
expression of PKA-WT, PKA-L206R, or empty
control.(Figure S4A). We next asked if DHX9 is a CN substrate whose nu-
clear localization might be regulated by KIF1Bb-dependent CN
enzymatic activity and observed that loss of CNA (shCNA) pre-
vents KIF1Bb-mediated DHX9 nuclear localization in NB1 cells
(Figure 5G). Consistent with these results, the previously identi-
fied DHX9 downstream target XAF1 was induced and translo-
cated to themitochondria upon KIF1Bb transduction, dependent
on CNA and CALM2 (Figure S5E).
Tumorigenic, Gain-of-Function, Mutant PKA Enhances
DRP1 Phosphorylation on Ser637 and Blocks
KIF1Bb-Induced Apoptosis
Protein kinase A (PKA) is essential for DRP1 phosphorylation at
Ser637, counteracting CNA phosphatase function, and thus in-
hibiting DRP1 mitochondrial localization and fission (Chang
and Blackstone, 2007; Dickey and Strack, 2011). Somatic,
tumorigenic mutations causing constitutive activation of PKA
have been identified in adrenal adenoma (Beuschlein et al.,
2014). The identified PKA gain-of-function mutation (L206R)
gives the PKA catalytic subunit resistance to enzymatic suppres-
sion by the regulatory subunit, and makes PKA constitutively
active even in the absence of cAMP. Thus, overexpression of
the L206R mutant causes increased PKA activity. We ques-
tioned whether these disease-causing PKA variants block
KIF1Bb-mediated apoptosis by maintaining DRP1 phosphoryla-
tion. Ectopic expression of wild-type PKA in NB1 cells had no
significant effect on KIF1Bb’s ability to induce apoptosis and
DRP1 dephosphorylation on Ser637 in NB1 cells, whereas the
PKA-L206R gain-of-function mutant significantly impaired both
KIF1Bb induced apoptosis and DRP1 dephosphorylation (Fig-Developmental Cell 36, 164–178ures 6A and 6B). Furthermore, expression
of PKA-L206R in SK-N-SH and SK-N-F1
(KIF1Bb+/+) neuroblastoma cells incre-
ased DRP1 phosphorylation (Figure 6C)and decreased mitochondrial DRP1 (Figures 6D and 6E). Chem-
ical treatment with forskolin, a compound commonly used to
activate PKA (Walsh and Van Patten, 1994), mirrored the effects
of constitutively active mutant PKA (L206R) on DRP1 phosphor-
ylation at Ser637, DRP1mitochondrial translocation, and KIF1B-
b-induced apoptosis (Figures S6A–S6C).
In summary, we conclude that the gain-of-function mutant
PKA blocks KIF1Bb-mediated apoptosis by preventing DRP1
mitochondrial translocation through constitutive phosphoryla-
tion of DRP1 on Ser637. These results reinforce the importance
of DRP1 phosphorylation for mitochondrial network dynamics
and KIF1Bb-induced apoptosis, while simultaneously suggest-
ing a tumor-suppressive function for DRP1 and KIF1Bb in other
forms of cancer that harbor activating tumorigenic PKA
mutations.
DRP1 Is Silenced in 1p36-Deleted and KIF1Bb-Deficient
Neuroblastoma Tumors and Prognostically Relevant in
High-Risk Disease
To investigate if DRP1 is a pathogenic target in neuroblastoma,
we analyzed 23 primary neuroblastoma tumors for DRP1,
CNA, and KIF1Bb protein expression. Among the primary neuro-
blastomas, 11 were 1p36 intact (1p36+/+) while seven tumors
harbored hemizygous 1p36 deletions, and in two tumors the
1p36 status was unknown (Figure 7A and S7I). CNA protein
expression varied across the different tumors independent of
the 1p36 status, however we observed a complete lack of
KIF1Bb and DRP1 expression in all 1p36 hemizygous-deleted
primary tumors in contrast to the 1p36-intact tumors. However,
mitochondrial content markers such as PGC1a, TFAM, COXIV,, January 25, 2016 ª2016 Elsevier Inc. 173
and mitochondrial fission protein MFN1 did not change among
the different tumors (Figure S7A).
The silencing of KIF1Bb and DRP1 in these 1p36 hemizygous-
deleted neuroblastoma tumors suggests that they are patho-
genic targets of this deletion. Indeed, low expression of KIF1Bb
and DRP1 is correlated with poor prognosis and reduced sur-
vival of neuroblastoma patients, further implicating KIF1Bb and
DRP1 as neuroblastoma tumor suppressors (Figures 7B and
7C). The expression of both DRP1 and KIF1Bb varies signifi-
cantly with disease stage and is lower in INSS stage 4 tumors
(Figures 7E and 7F). In addition, we included KIF1Balpha isoform
expression in the analysis as a control, showing no significant
correlation with reduced survival (Figure 7D) and no reduction
in expression in advanced disease (Figure 7G). This indicates
that the correlation between low expression of KIF1Bb and
worse patient outcome is not simply a bystander effect of 1p36
deletion, but rather a specifically relevant observation for neuro-
blastoma prognosis.
Allelic loss of chromosome 1p36 in neuroblastoma has been
correlated with N-myc amplification (Caron et al., 1993). Thus,
the association of KIF1Bb with prognosis and high-risk disease
(stage 4) could be influenced by NMYC amplification. However,
we found that low KIF1Bb and DRP1 expression correlates with
worse outcome (event-free survival) in non-N-myc amplified
neuroblastoma (Figures S7B and S7C), whereas KIF1Balpha
does not (Figure S7D). Furthermore, the levels of KIF1Bb and
DRP1 are prognostically relevant and decreased in stage 4 dis-
ease in non-NMYC-amplified neuroblastoma, but not in
NMYC-amplified neuroblastoma (Figures S7E–7H).
In accord with these findings, genes in KEGG pathways
involving mitochondrial metabolism and oxidative phosphoryla-
tion significantly correlate with the expression of KIF1Bb or
DRP1 in neuroblastoma patients using the R2 pathway finder
at the R2 visualization platform (http://r2.amc.nl, data not
shown).
DISCUSSION
KIF1Bb is a candidate 1p36 tumor suppressor gene that regu-
lates developmental apoptosis in the sympathetic nervous sys-
tem when neural progenitors compete for NGF (Munirajan
et al., 2008; Schlisio et al., 2008). However, bona fide proof of
its tumor-suppressive function and the nature of that function
remain elusive. Here we found a complete lack of KIF1Bb
expression in 1p36 hemizygous-deleted primary neuroblastoma
tumors in contrast to 1p36 intact tumors, indicating that KIF1Bb
is a pathogenic target of 1p36 deletions. Investigating the mech-
anism of KIF1Bb tumor suppression, we found that KIF1Bb reg-
ulates mitochondrial dynamics by mediating mitochondrial
translocation of the mitochondrial fission protein DRP1. Mito-
chondrial translocation of DRP1 is required for mitochondrial
fission (Knott et al., 2008) and for KIF1Bb to induce apoptosis,
and loss of DRP1 promotes survival in NGF-deprived neurons.
Excess cell survival during NGF-dependent developmental cull-
ing of neuronal progenitors might therefore set the stage for neo-
plasmic transformation. In this respect, we found that previously
identified KIF1Bb disease-associated variants in neuroblastoma
and pheochromocytoma all fail to regulate DRP1. Indeed, DRP1
is silenced along with KIF1Bb in 1p36 hemizygous-deleted neu-174 Developmental Cell 36, 164–178, January 25, 2016 ª2016 Elseviroblastomas and low expression is correlated with poor prog-
nosis and reduced survival in these patients. Thus, DRP1 might
be a pathogenic target in neuroblastoma. Furthermore, low
KIF1Bb and DRP1 expression correlates with worse outcome
(event-free survival and stage 4) in non-N-myc amplified neuro-
blastoma. In accord with these findings, Martinson and col-
leagues demonstrated that 11q-deleted tumors constitute a
distinct group of unfavorable neuroblastoma tumors that differ
from those of the other important high-risk neuroblastoma
group, the NMYC-amplified group (Caren et al., 2010). Impor-
tantly, the 11q-deleted group (no NMYC amplification) feature
more distal 1p deletions (consensus in 0–10.4 Mb) that include
the KIF1B locus, in contrast to the NMYC-amplified group that
harbors more proximal deletions (17–32 Mb). Thus, 1p-deletion
in 11q-LOH tumors might specifically involve KIF1Bb, suggest-
ing that an unknown 11q tumor suppressor may collaborate
with loss of KIF1Bb in high-risk neuroblastoma pathogenesis,
rather than collaborating with NMYC amplification.
We observed mutual silencing of KIF1Bb and DRP1 in 1p36
hemizygous-deleted neuroblastoma tumors, although in neuro-
blastoma cell lines we only observed KIF1Bb-dependent
changes in DRP1 phosphorylation and mitochondrial transloca-
tion, not expression. Although KIF1Bb loss blocks DRP1 mito-
chondrial translocation, additional selection pressure in the
tumors may favor ablation of any residual mitochondrial DRP1
activity, or other functions of DRP1 not discussed here. In this re-
gard, recent findings demonstrated that DRP1 plays a key role in
membrane fission, receptor-mediated endocytosis, synaptic
vesicle recycling, and possibly vesicle trafficking (Hinshaw,
2000; Li et al., 2013). Thus, silencing of DRP1 could conceivably
impair NGF receptor internalization, and signaling, and lay the
path for NGF independence and neuronal de-differentiation in
nascent neuroblastoma cells.
Previous reports demonstrate that DRP1 activity is controlled
by phosphorylation on Ser637 by PKA. DRP1 phosphorylation
contributes to mitochondrial elongation by keeping DRP1 in
the cytoplasm (Cribbs and Strack, 2007). We found that tumori-
genic PKA gain-of-function mutations identified in adrenal ade-
nomas block KIF1Bb-mediated apoptosis by preventing DRP1
mitochondrial translocation through constitutive phosphoryla-
tion of DRP1 on Ser637. Thus, mitochondrial fission mediated
by DRP1 might therefore be deregulated in other cancers that
harbor activating tumorigenic PKA mutations. In contrast to
PKA, CN reverses DRP1 inhibition by dephosphorylating
Ser637. This allows DRP1 translocation to the mitochondria
and subsequent mitochondrial division (Cereghetti et al., 2008).
We demonstrated that KIF1Bb promotes mitochondrial fission
by promoting CN-dependent dephosphorylation of DRP1 on
Ser637.
KIF1Bb binds to the Ca2+ sensor and adaptor protein CALM2,
a key regulator of CN activity. TheC-terminal inhibitory domain of
CNA inhibits its own catalytic site, however, binding of Ca2+-
saturated CALM2 relieves this inhibition, and thus CALM2 bind-
ing is crucial for CN activation (Li et al., 2011). We found that
endogenous CNA-CALM2 interaction requires KIF1Bb, which
acts as a scaffold to potentiate and stabilize the CNA-CALM2
complex. We considered the possibility that KIF1Bb might
enhance CNA-CALM2 binding by affecting the intracellular
Ca2+ concentration, since CNA binds CALM2 with higher affinityer Inc.
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Figure 7. DRP1 Is Silenced in 1p36 Deleted and KIF1Bb-Deficient Neuroblastoma Tumors
(A) Immunoblot of primary neuroblastoma tumors. 1p36 status has been characterized and shown as indicated. SK-N-SH cells (1p36+/+) and NB1 cells (1p36/)
served as control. The question mark indicates the unknown 1p36 status.
(B–D) Kaplan-Meier overall survival curve for individuals with high (blue) and low (red) expression of (B) KIF1Bb, (C) DRP1, and (D) KIF1Balpha using the Tumor
Neuroblastoma public-SEQC-498 dataset from the R2: microarray analysis and visualization platform (http://r2.amc.nl). The KIF1B reporter is specific for the
KIF1Bb or alpha splice variant and not cross-reactive to a or b respectively. The graph depicts the best p value corrected for multiple testing (Bonferroni
correction). The numbers in parentheses indicate the number of individuals in each group.
(legend continued on next page)
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in Ca2+-saturated conditions. Therefore, we studied the effect of
KIF1Bb onCNphosphatase activity in Ca2+-saturated conditions
using phospho-Ser637-DRP1 peptide and could only detect
DRP1-dephosporylation by CN if we added KIF1Bb. Likewise,
P-DRP1 peptide bound with high affinity to CNA only in the pres-
ence of KIF1Bb. The apoptosis-inducing region of KIF1Bb span-
ning aa 600–1400 overlaps with the region that regulates CN
activation and CN is required for KIF1Bb to induce apoptosis.
That the KIF1Bb600-1400 region excludes the motor domain
indicates that CNA activation, DRP1 dephosphorylation causing
mitochondrial fission, and apoptosis occur independent of
KIF1Bb cargo-trafficking motor function.
We hypothesized that KIF1Bb has a general role in CN regula-
tion and demonstrated that for all the known substrates we
tested, KIF1Bb was required for CN substrate recognition and
dephosphorylation. Thus, loss of KIF1Bb potentially deregulates
a wide range of CN-mediated signaling cascades, and probably
affects CN activity in the range of tissues and physiological con-
texts where KIF1Bb is normally expressed. While our model for
KIF1Bb-CN activation is valid in cellular contexts where KIF1Bb
is expressed, other adaptor proteins are presumably required for
CN activation in cell types and tissues that do not express
KIF1Bb. In this respect, we recently observed expression of
KIF1Bb in the peripheral ganglia but not in non-neuronal tissue
surrounding the ganglia (Chen et al., 2014). Furthermore, we
observed KIF1Bb expression in the brain and in neural crest-
derived tissues such asmelanocytes (data not shown). However,
we speculate that other scaffolding proteins might regulate CN
activity in cell types where KIF1Bb is not expressed.
We also identified a potential CN substrate, RNA helicase A
(DHX9). We recently demonstrated that KIF1Bb stimulates nu-
clear accumulation of RNA helicase A (DHX9), causing induction
of the proapoptotic XIAP-associated factor 1 (XAF1) followed by
apoptosis, but the mechanism behind DHX9 nuclear transloca-
tion remained unknown (Chen et al., 2014). Here we showed
that DHX9 contains a CN recognition motif (LxVP) at amino
acid residues 647–650 that, as with the other substrates, is
only recognized and bound by CN in the presence of KIF1Bb.
Consistent with these results, the KIF1Bb/DHX9 downstream
target XAF1 was induced and translocated to the mitochondria
upon KIF1Bb induction, and this required CN and CALM2.
Finally, we argue that the previous, widely accepted model in
which Ca2+ and CALM2 binding is sufficient for CN activation
needs to be revised (Figure 7D). Supporting our proposedmech-
anism of activation, previous reports showed that CN is poorly
activated under saturated Ca2+ conditions despite the presence
of CALM2 (Wang et al., 2008). Here we propose that CALM2
binding in Ca2+ saturated conditions is necessary, but not suffi-
cient, for CN activity and that full displacement of the CNA auto-
inhibitory domain and full enzymatic activation requires the(E–G) Boxplot representing KIF1Bb (E), DRP1 (F), or KIF1Balpha (G) expression fo
SEQC-498 dataset from the R2: microarray analysis and visualization platform.
(H) Model of the proposedmechanism of CNA activation by KIF1Bb. In a widely ac
autoinhibitory domain. Activation requires Ca2+ binding on the regulatory subuni
change that displaces partial the autoinhibitory domain from the active site resulti
full activation of CNA. The kinesin KIF1Bb acts as a scaffold through direct interact
the CALM2-CNA complex and thus displacing fully the autoinhibitory domain, resu
CNA and CALM2 are modified from PDB: 1AUI and 1a29, respectively.
176 Developmental Cell 36, 164–178, January 25, 2016 ª2016 Elseviscaffolding function of an allosteric coactivator, such as the
KIF1Bb 600–1400 aa region (Figure 7H).
EXPERIMENTAL PROCEDURES
Subcellular Fractionation
Cells were rinsed in ice-cold PBS/1 mM EDTA, collected by centrifugation
(5 min at 700 3 g), resuspended in HEPES-mannitol-sucrose buffer (10 mM
HEPES [pH 7.5], 210 mMmannitol, 70 mM sucrose, 1 mM EDTA) and homog-
enized by six passages through a 25G needle. The homogenate was centri-
fuged for 5 min at 2000 3 g to pellet nuclei and unlysed cells, and the
supernatant was centrifuged for another 10 min at 13,000 3 g to recover the
mitochondria. The crude mitochondrial pellet was resuspended in 10 mM
HEPES (pH 7.5), 210 mM mannitol, 70 mM sucrose, and 100 mM EGTA and
washed twice by 10 min centrifugation at 10,000 3 g.
Quantification of Mitochondrial Morphology
Mitochondrial morphology was assessed by immunofluorescence of cotrans-
fected cells with pDSRed-Mito and GFP- or Flag-KIF1Bb. 40–60 transfected
cells were analyzed for mitochondrial circularity and interconnectivity. Mito-
chondrial morphology (circularity and interconnectivity) was analyzed using
mitochondria channel images from the ImageJ macro created for NIH Image.
The red channel (mitochondria-targeted fluorescent protein pDsRed2-Mito)
wasprocessedandextracted tograyscale, inverted to showmitochondrial fluo-
rescence as black pixels. Themacro can draw individual outlines for eachmito-
chondrion and calculate the average circularity, average perimeter, average
area, average area/perimeter ratio. The mean mitochondrial circularity was
used as ameasure of mitochondrial fragmentation and the area/perimeter ratio
was used as an index of mitochondrial interconnectivity (Dagda et al., 2009).
DRP1 Mitochondrial Localization Studies
Endogenous DRP1 was assessed by immunofluorescence of cotransfected
NB1 cells with pDSRed-Mito and Flag-KIF1Bb pcDNA3. Colocalization of
endogenous DRP1 with mitochondria was analyzed by overlapping the red
and green channels and was quantified as Pearson’s coefficient using the
JaCoP plug-in for ImageJ software. 40–60 cells were analyzed 36 hr posttrans-
fection. In addition, mitochondrial fractionation was performed on NB1 cells
that were transduced with lentiviral encoding Flag-KIF1Bb. 36 hr postinfection
mitochondria were isolated for anti-DRP1 immunoblot analysis.
CN Phosphatase Assay
CNA, CALM2, KIF1Bbwere translated in vitro (TnT T7 QuickMater Mix). Reac-
tions contained 35S-methionine (Amersham cat. no. AG1094) and 40 ml of
Quick Mater Mix. Reactions were incubated at 30C for 90 min. Different com-
binations of CNA, CALM2, KIF1Bb were added to the reaction containing 1 mg
of biotinylated P-DRP1 peptide in dephosphorylation buffer: 50 mM Tris
(pH 8.6), 20 mM MgCl2, 1 mM DTT, 0.1 mg/ml BSA, and 0.1 mM CaCl2. The
reaction was incubated at 30C for 1 hr and stopped by adding EGTA
(5 mM). 25 ml of streptavidin agarose slurry was added for 1 hr and washed
five times with wash buffer containing 0.5% NP40, 150 mM NaCl, 10 mM
Tris-HCl. The pellet was boiled in Sample Buffer and analyzed by immunoblot.
In addition, CN phosphatase was measured using a recombinant/purified
CN kit (Abcam ab139461) to quantify phosphate release from p-RIIa-peptide
and p-DRP1-peptide by colorimetry. Flag-KIF1Bb was produced by in vitro
translation and purified by immunoprecipitation using Anti-Flag-M2 Affinity
Gel (Sigma) overnight at 4C, washed five times with TBS buffer, and eluted
from Flag-M2 beads by adding Flag peptide (F3290, Sigma). 25 ml of CN assayr individuals according to INSS stage using the Tumor Neuroblastoma public-
ceptedmodel, CNA (shown in red) catalytic activity is inhibited by its C-terminal
t B (CNB in green) and calmodulin (CALM2 in gray), causing a conformational
ng in partial activation. Here we propose an additional mechanism required for
ion with CALM2 and CNAwithin the 1000–1400 aa region of KIF1Bb, stabilizing
lting in full activation and thus allowing substrate recognition. The depictions of
er Inc.
buffer containing 0.5 mM CALM2 (final concentration 0.25 mM), 5 ml of diluted
CN (8 U) were recommended by the kit, however 1/10 dilutions of CN/
CALM2 were used in the activity assay in Figures 4D, 4F, and S5C (final con-
centrations: 1/10 CN dilution = 4 U; 1/10 CALM2 dilution = 0.025 mM). 10 ml of
eluted Flag-KIF1Bb was added to wells in a microtiter plate and equilibrated.
The reaction was started by the addition of CN substrate (final concentration =
0.15 mM P-DRP1 peptide or RII peptide) at 30C for 1 hr and terminated by
100 ml of Green Assay Reagent. Reaction color was developed for 25 min
and OD620 nm was read on a microtiter plate reader.
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